Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply

Lancet. 2017 Dec 2;390(10111):2436. doi: 10.1016/S0140-6736(17)32463-7. Epub 2017 Dec 1.

¹ Department of Gastroenterology, Akershus University Hospital, Lørenskog 1478, Norway. Electronic address: krikjo@online.no.
² Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway; Centre for Immune Regulation, Department of Immunology, Oslo, Norway.
³ Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
⁴ Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
⁵ Department of Gastroenterology, Akershus University Hospital, Lørenskog 1478, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

No abstract available

Publication types